Aa
Aa
A
A
A
Close
Avatar universal

Failed copaxone

I've been taking is copaxone, and it hasn't been working so I'm switching medications. I'm not really sure which medicine I should take next does anyone have any suggestions?
2 Responses
Sort by: Helpful Oldest Newest
Avatar universal
Yes this info was helpful thank you!
Helpful - 0
5112396 tn?1378017983
I'm sorry it didn't work out for you. The good news is it's unique among the injectables in that it's not an interferon. In other words, that fact that it didn't work for you doesn't automatically scratch any others off the list.

As you probably know, these days there are several oral drugs in addition to the older injectables. There are also infusions available if your MS has progressed.

I think the best course of action is probably to have a think about what will work best with your lifestyle and personal preferences and then discuss it with your neurologist in terms of what will be most likely to succeed where Copaxone did not.

Also, remember that ALL disease-modifying drugs play the long game. They do not treat symptoms. They do not fix old damage. Their goal is to reduce the number of relapses and hopefully slow down disease progression over time.

Hope this is helpful!
Helpful - 0
Have an Answer?

You are reading content posted in the Multiple Sclerosis Community

Top Neurology Answerers
987762 tn?1671273328
Australia
5265383 tn?1669040108
ON
1756321 tn?1547095325
Queensland, Australia
1780921 tn?1499301793
Queen Creek, AZ
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Popular Resources
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease